Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma

Diagnostic Cytopathology

Volumn 40, Issue 4, 2012, Pages 346-351

  Huang, Jing ^a   Zhang, Pei Hong ^a   Gao, Yu Huan ^b   Qiu, Lu Gui ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

angioimmunoblastic T cell lymphoma (AITL); diffuse large B cell lymphoma (DLBCL); Epstein Barr virus (EBV); IgH gene rearrangement; TCR gene rearrangement

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE; IFOSFAMIDE; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON REGULATORY FACTOR 4; PREDNISONE; RITUXIMAB; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR PAX5; VINCRISTINE;

ADULT; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GENE REARRANGEMENT; HEART FAILURE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLAST; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LUNG MYCOSIS; LYMPH NODE BIOPSY; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY FAILURE; T CELL LYMPHOMA; THERAPY EFFECT; TREATMENT RESPONSE;

GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 84857370937     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21641     Document Type: Article

References (27)

1. Iannitto E, Ferreri AJ, Minardi V, et al. Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol 2008; 68: 264-271.
2. Dogan A, Gaulard P, Jaffe ES, et al. Angioimmunoblastic T-cell lymphoma. In:, Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p 309-311.
3. Dunleavy K, Wilson WH, Jaffe ES,. Angioimmunoblastic T cell lymphoma: Pathobiological insights and clinical implications. Curr Opin Hematol 2007; 14: 348-353. (Pubitemid 46842809)
4. Pangalis GA, Moran EM, Nathwani BN, et al. Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer 1983; 52: 318-321. (Pubitemid 13063175)
5. de Leval L, Gaulard P,. Pathobiology and molecular profiling of peripheral T-cell lymphomas. Hematol Am Soc Hematol Educ Program 2008; 272-279.
6. Anagnostopoulos I, Hummel M, Finn T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992; 80: 1804-1812.
7. Zhou Y, Attygalle AD, Chuang SS, et al. Angioimmunoblastic T-cell lymphoma: Histological progression associates with EBV and HHV6B viral load. Br J Haematol 2007; 138: 44-53. (Pubitemid 46889786)
8. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99: 627-633. (Pubitemid 34533101)
9. Grogg KL, Attygalle AD, Macon WR, et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma peripheral T-cell lymphoma, unspecified. Mod Pathol 2006; 19: 1101-1107. (Pubitemid 44106725)
10. Dorfman DM, Brown JA, Shahsafaei A, et al. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006; 30: 802-810. (Pubitemid 44264969)
11. Yu H, Shahsafaei A, Dorfman DM,. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 2009; 131: 33-41.
12. Tan BT, Warnke RA, Arber DA,. The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: A comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 2006; 8: 466-475. (Pubitemid 44377929)
13. de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952-4963. (Pubitemid 46827794)
14. Huang Y, Moreau A, Dupuis J, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009; 33: 682-690.
15. Abruzzo LV, Schmidt K, Weiss LM, et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: A case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993; 82: 241-246. (Pubitemid 23188770)
16. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002; 117: 368-379. (Pubitemid 34226071)
17. Maegawa RO, Hussain S, Danila DC, et al. Angioimmunoblastic T-cell lymphoma with an evolving Epstein Barr virus-positive diffuse large B-cell lymphoma with unusual clinical and pathologic findings. Leuk Lymphoma 2007; 48: 2071-2074. (Pubitemid 47542998)
18. Willenbrock K, Bräuninger A, Hansmann ML,. Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 2007; 138: 733-739. (Pubitemid 47313216)
19. Skugor ND, Perić Z, Vrhovac R, et al. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Coll Antropol 2010; 34: 241-245.
20. Yawalkar N, Ferenczi K, Jones DA, et al. Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 2003; 102: 4059-4066. (Pubitemid 37486989)
21. Kluin-Nelemans HC, Coenen JL, Boers JE, et al. EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma. Blood 2008; 112: 1039-1041.
22. Johnston A, Salles G, Espinouse D, et al. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy. Clin Lymphoma Myeloma 2008; 8: 356-358.
23. Foss HD, Anagnostopoulos L, Herbst H, et al. Pattern of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1995; 85: 2862-2869.
24. Tosato G, Seamon KB, Goldman ND, et al. Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2. IL-6). Science 1998; 239: 502-504.
25. Young LS, Rickinson AB,. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-768. (Pubitemid 39331148)
26. Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL? Leukemia 2002; 16: 2134-2141. (Pubitemid 35203459)
27. Abruzzo LV, Griffith LM, Nandedkar M, et al. Histologically discordant lymphomas with B-cell and T-cell components. Am J Clin Pathol 1997; 108: 316-323. (Pubitemid 27371651)